Works by Brüning, Fabian


Results: 12
    1

    Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study).

    Published in:
    Cancers, 2021, v. 13, n. 11, p. 2594, doi. 10.3390/cancers13112594
    By:
    • Zeuschner, Philip;
    • Hölters, Sebastian;
    • Stöckle, Michael;
    • Seliger, Barbara;
    • Mueller, Anja;
    • Bachmann, Hagen S.;
    • Grünwald, Viktor;
    • Christoph, Daniel C.;
    • Stenzl, Arnulf;
    • Grimm, Marc-Oliver;
    • Brüning, Fabian;
    • Goebell, Peter J.;
    • Augustin, Marinela;
    • Roos, Frederik;
    • Harde, Johanna;
    • Benz-Rüd, Iris;
    • Staehler, Michael;
    • Junker, Kerstin
    Publication type:
    Article
    2
    3
    4
    5
    6

    Everolimus after failure of one prior VEGF‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC‐2 trial.

    Published in:
    International Journal of Cancer, 2021, v. 148, n. 7, p. 1685, doi. 10.1002/ijc.33349
    By:
    • Staehler, Michael;
    • Stöckle, Michael;
    • Christoph, Daniel C.;
    • Stenzl, Arnulf;
    • Potthoff, Karin;
    • Grimm, Marc‐Oliver;
    • Klein, Dunja;
    • Harde, Johanna;
    • Brüning, Fabian;
    • Goebell, Peter J.;
    • Augustin, Marinela;
    • Roos, Frederik;
    • Benz‐Rüd, Iris;
    • Marschner, Norbert;
    • Grünwald, Viktor
    Publication type:
    Article
    7
    8
    9
    10
    11
    12